2 unknown, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Completed 1 |
Follow Vitrectomy: new trials by email Literature Review of Vitrectomy trials Research Report on Vitrectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker. Dexamethasone Intracanalicular Insert, 0.4 mg, Prednisone acetate 1% - Vitrectomy, Macular Pucker | Phase 4 | Unknown | Kovach Eye Institute | 60 | 2021-04-27 | 2023-06-29 |
| Oral Sedation in Vitreoretinal Surgery Oral Sedatives with or Without Analgesia, Intravenous Sedatives with or Without Analgesia - Macular Holes, Intraocular Lens Opacification | Phase 4 | Unknown | Rocky Vista University, LLC | 80 | 2020-06-01 | 2020-04-15 |
| Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1% Nepafenac, Ketorolac LS, Bromfenac - Vitrectomy | Phase 4 | Completed | Innovative Medical | 2008-09-25 |
Epiretinal Membrane (2) · Papilledema (1) · Retinal Detachment (1) · Retinal Perforations (1) · Vitreous Detachment (1) · Vitreous Hemorrhage (1)
Eye Diseases (2) · Retinal Diseases (2) · Cranial Nerve Diseases (1) · Eye Hemorrhage (1) · Hemorrhage (1) · Nervous System Diseases (1) · Optic Nerve Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Analgesia (1) · Hypnotics and Sedatives (1) · bromfenac (1) · nepafenac (1)
Innovative Medical (1) · Kovach Eye Institute (1) · Rocky Vista University, LLC (1)
United States (2)
Jeffrey Heier, MD (1) · Saad Ahmad, MD (1)